Diagnostics

Politan Nominates Two Independent Candidates for Masimo Board

Supports Strategic Review of Consumer Business, But Has Serious Concerns Given Masimo’s Broken Governance and Lack of Independent Oversight Nominees…

8 months ago

CMTA Board Evolution: Welcoming Bernard Coulie and Kevin Marks

Bernard Coulie and Kevin Marks bring significant corporate, drug development, and compliance experience to the CMTA BoardThe CMTA Board and…

8 months ago

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:…

8 months ago

Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic

Plus’ CSF-01 cancer cell enumeration test is a sensitive and specific diagnostic test for the presence of adenocarcinoma and melanoma…

8 months ago

GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare

MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based…

8 months ago

GE HealthCare Announces Cash Dividend for First Quarter of 2024

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per…

8 months ago

GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases and health conditions Scientific studies…

8 months ago

Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners

Babson introduces BetterWay™ blood testing, which uses a pea-sized amount of blood collected from a finger to produce results equivalent…

8 months ago

Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships

VANCOUVER, BC / ACCESSWIRE / March 21, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to…

8 months ago